A Hallucinogenic Root Is Pitched to Davos Set as Treatment for Opioid Addiction
This article is for subscribers only.
Sign up here to receive the Davos Diary, a special daily newsletter that will run from Jan. 20-24.
The World Economic Forum’s billionaire audience in Davos took a break from the problem of climate change to listen to the story of a company developing a hallucinogenic drug.